Harvard University-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2023

  1. Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium

    PLoS ONE, Vol. 18, Núm. 1 January

  2. Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium

    eClinicalMedicine, Vol. 64

  3. Potential pitfalls in the use of real-world data for studying long COVID

    Nature Medicine

2022

  1. International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality

    npj Digital Medicine, Vol. 5, Núm. 1

2021

  1. ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing

    BMC infectious diseases, Vol. 21, Núm. 1, pp. 5

2020

  1. Outcomes of second-line antiretroviral therapy among children living with HIV: a global cohort analysis

    Journal of the International AIDS Society, Vol. 23, Núm. 4

2019

  1. Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list

    The Lancet HIV, Vol. 6, Núm. 9, pp. e623-e631

2018

  1. The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis

    PLoS Medicine, Vol. 15, Núm. 3

2016

  1. Safety of darunavir and atazanavir in HIV-infected children in Europe and Thailand

    Antiviral Therapy, Vol. 21, Núm. 4, pp. 353-358